Literature DB >> 24158645

The contralateral extremity has also benefit from the locally administered bone marrow-derived mononuclear cells and cord blood serum in diabetic ischemic wound healing.

A Tulga Ulus1, Ferda Alpaslan Pınarli, Devrim Sonmez, Ahmet Yesilyurt, Tuncay Delibasi.   

Abstract

OBJECTIVE: Impaired wound healing could be a disaster especially in diabetes and amputation is the major risk. The aim of this study was to evaluate the benefit of BMMCs and CBS on wound healing.
METHODS: Diabetic rats were underwent bilateral limb ischemia and wounding of skin defects on both extremities. The groups were formed as BMMCs (group A), BMMCs and CBS (group B), only CBS (group C), and phosphate buffer solution (group D) that were injected into wounds on right legs.
RESULTS: The complete recovery of right legs was established as a mean of 21.4 ± 1.1 days, 12.9 ± 1.5 days, 30.0 ± 0.0 days and 38.1 ± 1.5 days according to Groups A, B, C, and D (p < 0.05). The recovery of left legs were calculated as a mean of 27.0 ± 0.0 days, 24.0 ± 0.0 days, 35.6 ± 1.1 days and 37.3 ± 1.6 days according to Groups A, B, C and D (p < 0.05). At the end of the recovery, the HE staining showed that vascularity was increased in groups A and B.
CONCLUSION: Transplantation of BMMCs and CBS to the ischemic wounds of the diabetic rats accelerate the repair. The recovery was also superior in the same group although the treatment was not applied to the left extremity directly.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24158645     DOI: 10.1007/s12015-013-9480-1

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  28 in total

1.  The TASC supplement - international recommendations for management of peripheral arterial disease.

Authors:  T V Schroeder
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-06       Impact factor: 7.069

2.  The market in diabetes.

Authors:  Alexandra Hauber; Edwin A M Gale
Journal:  Diabetologia       Date:  2006-02       Impact factor: 10.122

3.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

Review 4.  Human umbilical cord blood cells: a new alternative for myocardial repair?

Authors:  J Leor; E Guetta; P Chouraqui; V Guetta; A Nagler
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

5.  The use of automated data to identify complications and comorbidities of diabetes: a validation study.

Authors:  K M Newton; E H Wagner; S D Ramsey; D McCulloch; R Evans; N Sandhu; C Davis
Journal:  J Clin Epidemiol       Date:  1999-03       Impact factor: 6.437

6.  Management of ischemic heel ulceration and gangrene: An evaluation of factors associated with successful healing.

Authors:  G S Treiman; G S Oderich; A Ashrafi; P A Schneider
Journal:  J Vasc Surg       Date:  2000-06       Impact factor: 4.268

7.  High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.

Authors:  Hal E Broxmeyer; Edward F Srour; Giao Hangoc; Scott Cooper; Stacie A Anderson; David M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-07       Impact factor: 11.205

8.  Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

Authors:  Berthold Amann; Claas Luedemann; Richard Ratei; J André Schmidt-Lucke
Journal:  Cell Transplant       Date:  2009-04-02       Impact factor: 4.064

9.  Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes.

Authors:  Cindy J M Loomans; Eelco J P de Koning; Frank J T Staal; Maarten B Rookmaaker; Caroline Verseyden; Hetty C de Boer; Marianne C Verhaar; Branko Braam; Ton J Rabelink; Anton-Jan van Zonneveld
Journal:  Diabetes       Date:  2004-01       Impact factor: 9.461

10.  Improved survival, vascular differentiation and wound healing potential of stem cells co-cultured with endothelial cells.

Authors:  Dora C S Pedroso; Ana Tellechea; Liane Moura; Isabel Fidalgo-Carvalho; João Duarte; Eugénia Carvalho; Lino Ferreira
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

View more
  1 in total

1.  The innate immune response to lower respiratory tract E. Coli infection and the role of the CCL2-CCR2 axis in neonatal mice.

Authors:  Sharon A McGrath-Morrow; Roland Ndeh; Joseph M Collaco; Amy K Poupore; Dustin Dikeman; Qiong Zhong; Benjamin D Singer; Franco D'Alessio; Alan Scott
Journal:  Cytokine       Date:  2017-06-16       Impact factor: 3.861

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.